(BBIO) BridgeBio Pharma - Performance 20.2% in 12m
Compare BBIO with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
9.02%
#32 in Group
Rel. Strength
75.52%
#1871 in Universe
Total Return 12m
20.21%
#34 in Group
Total Return 5y
38.51%
#33 in Group
P/E -
(unknown) Percentile in Group
P/E Forward -
(unknown) Percentile in Group
PEG -
(unknown) Percentile in Group
FCF Yield -6.49%
(unknown) Percentile in Group
12m Total Return: BBIO (20.2%) vs XBI (-11%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
| UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
| AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
| LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
| NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
| BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
| KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: BBIO vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BBIO
| Total Return (including Dividends) | BBIO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 4.88% | -5.85% | -3.01% |
| 3 Months | 22.77% | -11.95% | -3.15% |
| 12 Months | 20.21% | -11.00% | 10.19% |
| 5 Years | 38.51% | 0.65% | 129.24% |
| Trend Score (consistency of price movement) | BBIO | XBI | S&P 500 |
| 1 Month | 63.2% | -59.8% | -5.5% |
| 3 Months | 21.4% | -70.5% | -58.4% |
| 12 Months | 45.0% | -6.9% | 84.1% |
| 5 Years | -32.3% | -50% | 84.4% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #39 | 11.4% | 8.13% |
| 3 Month | #13 | 39.4% | 26.8% |
| 12 Month | #33 | 35.1% | 9.09% |
| 5 Years | #35 | 37.6% | -39.6% |
FAQs
Does BBIO BridgeBio Pharma outperforms the market?
Yes,
over the last 12 months BBIO made 20.21%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months BBIO made 22.77%, while XBI made -11.95%.
Over the last 3 months BBIO made 22.77%, while XBI made -11.95%.
Performance Comparison BBIO vs Indeces and Sectors
BBIO vs. Indices BBIO is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -3.38% | 7.89% | 38.2% | 10.0% |
| US NASDAQ 100 | QQQ | -2.40% | 8.94% | 38.9% | 11.6% |
| US Dow Jones Industrial 30 | DIA | -3.58% | 7.02% | 37.3% | 10.7% |
| German DAX 40 | DAX | -2.08% | 8.26% | 21.4% | -1.48% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -3.09% | 4.65% | 53.4% | 11.1% |
| Hongkong Hang Seng | HSI | -5.35% | 2.11% | 47.4% | 2.88% |
| India NIFTY 50 | INDA | -4.41% | -2.99% | 48.5% | 19.5% |
| Brasil Bovespa | EWZ | -3.49% | -3.41% | 46.2% | 32.0% |
BBIO vs. Sectors BBIO is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.84% | 8.69% | 30.1% | 1.0% |
| Consumer Discretionary | XLY | -4.14% | 8.71% | 34.8% | 6.15% |
| Consumer Staples | XLP | -6.17% | 6.72% | 37.3% | 9.18% |
| Energy | XLE | -4.47% | -3.14% | 32.6% | 19.4% |
| Financial | XLF | -3.86% | 7.58% | 26.0% | -2.04% |
| Health Care | XLV | -3.80% | 8.04% | 42.9% | 18.5% |
| Industrial | XLI | -3.69% | 5.57% | 38.9% | 11.7% |
| Materials | XLB | -4.48% | 4.37% | 46.3% | 24.2% |
| Real Estate | XLRE | -5.42% | 7.57% | 41.3% | 6.85% |
| Technology | XLK | -2.25% | 8.89% | 43.3% | 18.2% |
| Utilities | XLU | -6.67% | 4.06% | 39.1% | -5.02% |
| Aerospace & Defense | XAR | -2.78% | 3.60% | 34.3% | -0.72% |
| Biotech | XBI | 1.18% | 10.7% | 55.9% | 31.2% |
| Homebuilder | XHB | -3.88% | 4.73% | 57.6% | 27.9% |
| Retail | XRT | -5.68% | 5.38% | 42.3% | 25.0% |